Ropes & Gray represented Lepu Biopharma in the transaction. Shanghai-based Lepu Biopharma Co., Ltd. (Stock Code: 02157.HK) announced an exclusive license agreement with ArriVent BioPharma (Nasdaq:...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Sanofi on the deal. Sanofi announced a strategic equity investment in Torino, Italy-based Resalis Therapeutics (Resalis Therapeutics). The company plans to use...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented ImmunoGen in the deal. ImmunoGen, Inc. announced a multi-target license and option agreement to research novel, first-in-class ADCs with ImmunoBiochem Corporation on the...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Ginkgo Bioworks on the deal. Ginkgo Bioworks, a horizontal platform for cell programming, announced the closing a transaction with Bayer for a...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Ginkgo Bioworks on the deal. Ginkgo Bioworks, a horizontal platform for cell programming, signed an agreement with Bayer to expand Ginkgo’s platform capabilities...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Verastem Oncology in the deal. Verastem Oncology announced a collaboration to evaluate Mirati Therapeutics’ investigational KRAS inhibitor drug with Verastem’s investigational inhibitor drug...
You must be a Standard 1 Year member to access this content.
